News from the life sciences and technology communities north of Boston
December 2022
Yesterday, Alpha-9 Theranostics of Boston and Vancouver announced the closing of $75 million Series B financing to advance its portfolio of radiopharmaceuticals for cancer treatment. The proceeds will support the progression of five candidates into the clinic. David Hirsch, M.D., Ph.D. is Alpha-9's CEO. Read more in Endpoints News.
Congratulations to Rgenta Therapeutics (300 TradeCenter, Woburn) on its recently announced $52 million Series A fundraising round led by AZ-CICC Healthcare Investment Fund. AZ-CICC Fund is a private equity fund jointly initiated by AstraZeneca and CICC Capital (China International Capital Corporation).

Rgenta is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Read more about the company and its latest funding in Boston Business Journal and Endpoints News.
"This platform is very broadly applicable to a range of previously undruggable targets. A lot of startup companies are struggling. This (funding) puts us in a very strong position."

Co-founder and CEO
Rgenta Therapeutics
The Prince and Princess of Wales met with Nth Cycle (100 Cummings Center, Beverly) during their visit to Greentown Labs last week.
CEO and co-founder Megan O'Connor (left photo, center), CFO Coleman Adams and Erika Gammon represented Nth as one of five companies aligned to the 2022 Earthshot Awards categories.

Read more in Vanity Fair and The Boston Globe.
ASTM International presented its top annual award – the Award of Merit – to Dr. Stephen Spiegelberg for his contributions to ASTM’s F04 Committee on Medical and Surgical Materials and Devices (F04).
The prestigious award, which includes the accompanying title of fellow, is ASTM’s highest recognition for distinguished service and outstanding participation in ASTM International committee activities. Spiegelberg is president of Cambridge Polymer Group (100 TradeCenter, Woburn).
100 TradeCenter, Woburn
New-construction Lab Now Available
This brand-new 2,477 SF lab suite has abundant natural light, high ceilings with upgraded linear pendant LED lighting, and direct tailgate loading.

Lab features include:
  • Tissue culture room with lab sink
  • 8’ chemical fume hood
  • Independent make-up air unit
  • Independent rooftop exhaust fan
  • Island casework with shelving 
  • 5 gallon acid neutralization tanks at each sink with associated plumbing
  • White metal casework and phenolic resin laboratory-type tops
  • Tempered emergency shower/eyewash stations
  • Vinyl composite tile flooring and white epoxy wall paint 
To learn more about this and other lab suites, contact leasing manager John Halsey at 781-982-7039 or sales@cummings.com.
Join North Shore Technology Council and its Biosciences, Sustainability, and Technology special interest groups for a Holiday Networking Event sponsored by Tobin Scientific, Great Sky Solar, and Venture Forward. Tuesday, December 20, 5:00 - 8:00 PM, True North Ale Company, Ipswich. Register.
MassBio hosts an Insider Recap of the annual J.P. Morgan Healthcare Conference, one of the largest and most informative healthcare investment symposiums in the industry. Hear a recap from three Conference insiders: Chris Garabedian, chairman and CEO, Xontogeny; Michal Preminger, head, Johnson & Johnson Innovation, East North America; and Rowan Walrath, life sciences reporter, Boston Business Journal. Tuesday, January 17, 8:00 - 10:00 AM, MassBio Hub, 700 Technology Square, Cambridge and virtual. Register.
Massachusetts Life Sciences Center has launched the 14th round of its Tax Incentive Program, open to companies engaged in life sciences research and development, commercialization, and manufacturing in Massachusetts. The program provides incentives to companies of all sizes looking to expand their efforts by creating new long-term jobs in Massachusetts.

The deadline to apply for the 2022-2023 program year is February 3, 2023. Learn more about the program and register for upcoming info sessions online.
The Medford and Tufts communities celebrated the opening of the MBTA Green Line Extension earlier this week. On hand to cut the ribbon were Lt. Governor Karen Polito, U.S. Senator Ed Markey, Governor Charlie Baker, U.S. Representative Katherine Clark, U.S. Senator Elizabeth Warren, Tufts President Anthony Monaco, and Medford Mayor Breanna Lungo-Koehn. The new stop is just a short walk to the Cummings life sciences campus on Boston Avenue and is adjacent to Tufts' Joyce Cummings Center.
Axial Therapeutics (300 TradeCenter, Woburn) is a is a clinical-stage biopharmaceutical company dedicated to improving the lives of people with conditions such as autism spectrum disorder and Parkinson’s disease by leveraging its understanding of the role of the microbiome and its impact on the nervous system.
Earlier this month, the Axial team gathered to sign more than 200 holiday cards created by Will from "With a Will, There is a Way.” Will is a high school student, business owner, and artist. He has autism and is nonverbal, and is an advocate for non-speakers. The company is is proud to support Will's great work by sharing the cards with its community this holiday season.
Nearly 20 life sciences client firms recently joined us for a holiday mixer at Strega Italiano in Woburn. Thanks to all who attended. Here's to a great year ahead!
We welcome your feedback on this newsletter and invite readers to share company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at svh@cummings.com to offer your news for upcoming newsletters. We look forward to hearing from you.
Keep up with news from the Cummings community by following us on LinkedIn, Facebook, Twitter, and Instagram.